These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11477746)

  • 1. History of sorbents in uremia.
    Winchester JF; Ronco C; Brady JA; Clemmer J; Muller TE; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Levin NW
    Contrib Nephrol; 2001; (133):131-9. PubMed ID: 11477746
    [No Abstract]   [Full Text] [Related]  

  • 2. Middle molecules re-examined.
    Henderson LW
    Nephron; 1978; 22(1-3):146-52. PubMed ID: 745634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale for combined hemoperfusion/hemodialysis in uremia.
    Winchester JF; Ronco C; Brady JA; Brendolan A; Davankov V; Tsyurupa M; Pavlova L; Pavlov M; Clemmer J; Polaschegg HD; Muller TE; La Greca G; Levin NW
    Contrib Nephrol; 2001; (133):174-9. PubMed ID: 11477750
    [No Abstract]   [Full Text] [Related]  

  • 4. Middle molecules as a marker of uremic toxins.
    Wu ZG; Liao LT; Cai ZH; Lu ZN; Cai YD; Sheng PF
    Adv Exp Med Biol; 1987; 223():33-7. PubMed ID: 3447449
    [No Abstract]   [Full Text] [Related]  

  • 5. Expectations for sorbents in uremia.
    Merrill JP
    Kidney Int Suppl; 1976 Dec; (7):S351-2. PubMed ID: 1070562
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of combined hemodialysis/hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Colì L; Prandini R; Bonomini V
    Contrib Nephrol; 1982; 29():123-32. PubMed ID: 6804167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Medium-sized molecules and the process of uremic intoxication].
    Lutz W
    Pol Tyg Lek; 1976 Jul; 31(27):1173-6. PubMed ID: 951302
    [No Abstract]   [Full Text] [Related]  

  • 8. A purification method by uncoated charcoal.
    Cerulli N; Politi L; D'Angelo AR; Scandurra R
    Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intestinal elimination of uremic metabolites by the adsorbents].
    Drüeke T
    Med Klin; 1976 Jan; 71(3):87-93. PubMed ID: 233947
    [No Abstract]   [Full Text] [Related]  

  • 10. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation and characterization of uremic metabolites in biologic fluids: a screening approach to the definition of uremic toxins.
    Gordon A; Berström J; Fürst P; Zimmerman L
    Kidney Int Suppl; 1975 Jan; (2):45-51. PubMed ID: 1057692
    [No Abstract]   [Full Text] [Related]  

  • 12. Adsorption of Protein-Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl-Immobilized Cellulose Beads in Patients Undergoing Hemodialysis.
    Yamamoto S; Sato M; Sato Y; Wakamatsu T; Takahashi Y; Iguchi A; Omori K; Suzuki Y; Ei I; Kaneko Y; Goto S; Kazama JJ; Gejyo F; Narita I
    Artif Organs; 2018 Jan; 42(1):88-93. PubMed ID: 28703401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Our experience with combined hemodialysis-hemoperfusion treatment in chronic uremia.
    Splendiani G; Albano V; Tancredi M; Daniele M; Pignatelli F
    Biomater Artif Cells Artif Organs; 1987; 15(1):175-81. PubMed ID: 3449135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a new coated charcoal for hemoperfusion in uremia.
    Stefoni S; Feliciangeli G; Coli L; Bonomini V
    Int J Artif Organs; 1979 Nov; 2(6):320-3. PubMed ID: 511374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sorbent membrane dialysis in uremia.
    Randerson DH; Gurland HJ; Schmidt B; Farrell PC; Hone PW; Stokoe C; Zuber A; Blogg A; Fateh-Moghadam A; Marschner I; Köpcke W
    Contrib Nephrol; 1982; 29():53-64. PubMed ID: 7075216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sorbents in the management of uremia.
    Friedman EA
    Perspect Nephrol Hypertens; 1977; 6():139-54. PubMed ID: 320549
    [No Abstract]   [Full Text] [Related]  

  • 17. Charcoal for the management of pruritus and uremic toxins in patients with chronic kidney disease.
    Cupisti A; Piccoli GB; Gallieni M
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):71-79. PubMed ID: 31725009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membranes and their removal of uremic toxins.
    Hoenich NA
    Adv Exp Med Biol; 1987; 223():253-62. PubMed ID: 3447443
    [No Abstract]   [Full Text] [Related]  

  • 19. Uremic toxins and peritoneal dialysis.
    Lameire N; Vanholder R; De Smet R
    Kidney Int Suppl; 2001 Feb; 78():S292-7. PubMed ID: 11169029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal perspectives on sorbents in uremia.
    Kolff WJ
    Kidney Int Suppl; 1976 Dec; (7):S211-4. PubMed ID: 1070535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.